Active substance
Volatile oils
- SFDA 7
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| ROWACHOL DROPS | Oral drops, solution · Oral use | 1 Bottle | SAR 7.35 | Generic · Prescription | ROWA-WAGNER | Withdrawn by regulatory authority · Not Marketed | |
| ROWACHOL DROPS | Oral drops, solution · Oral use | 1 Bottle | SAR 13.50 | Generic · Prescription | ROWA-WAGNER | Withdrawn by regulatory authority · Not Marketed | |
| ROWATINEX CAPS | Capsule · Oral use | 30 Tablet Container | SAR 7.15 | Generic · Prescription | ROWA-WAGNER | Withdrawn by regulatory authority · Not Marketed | |
| ROWATINEX CAPS | Capsule · Oral use | 100 Tablet Container | SAR 19.05 | Generic · Prescription | ROWA-WAGNER | Withdrawn by regulatory authority · Not Marketed | |
| ROWATINEX CAPS | Capsule · Oral use | 50 Tablet Container | SAR 10.50 | Generic · Prescription | ROWA-WAGNER | Withdrawn by regulatory authority · Not Marketed | |
| ROWATINEX DROPS | Oral drops, solution · Oral use | 1 Bottle | SAR 13.50 | Generic · Prescription | ROWA-WAGNER | Withdrawn by regulatory authority · Not Marketed | |
| ROWATINEX DROPS | Oral drops, solution · Oral use | 1 Bottle | SAR 7.35 | Generic · Prescription | ROWA-WAGNER | Withdrawn by regulatory authority · Not Marketed |
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.